Sana Biotechnology has bought central nervous system therapy developer and portfolio company Oscine, which is founded on University of Rochester research.

The MIT Media Lab-focused deep tech venture firm is back with its second fund having secured $24.6m of a targeted $80m from unnamed investors.

The series C funding will help Western Michigan portfolio company Shoulder Innovations build on the launch of its flagship shoulder replacement product.

Campbell Soup-backed Acre Venture Partners has made a strategic investment in fungi-based protein supplier Meati to bring its funding total to more than $32m.

The lidar chip developer will secure $120m in financing from investors including existing backer Porsche as it agrees to merge with InterPrivate Acquisition Corp.

The television engagement data provider added SIG Asia Investments to a base of corporate backers already including Itochu Technology Ventures.

Capital One Ventures was among the participants in a series B round for Stensul, a developer of enterprise email assembly software.

The MIT cell therapy spinout priced its shares at the bottom of their range to raise $70.6m, following some $166m in venture funding.

Zeal Capital Partners has secured $22.3m for its debut fund, which was anchored by PayPal as part of a $50m diversity commitment.

Q&A with John Banta, president and managing director, Blue Venture Fund